---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-017494"
form_type: "8-K"
ticker: null
cik: "0001310527"
company_name: "QSAM Biosciences, Inc."
filed_at: "2024-05-02T23:59:59+00:00"
generated_at: "2026-06-03T00:06:03.168288+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# QSAM Biosciences effects 1-for-2,000 reverse stock split; shares reduced to ~2,127

## Summary
- Reverse split effective May 2, 2024, converting each 2,000 shares into 1 share.
- Outstanding shares reduced to approximately 2,127 shares from pre-split count.
- Fractional shares compensated with cash (~$13,210.58 per fractional) plus one CVR.
- Reverse split is a condition precedent for pending merger with Telix Pharmaceuticals.

## SEC filing metadata
- accession: 0001493152-24-017494
- form_type: 8-K
- cik: 0001310527
- company_name: QSAM Biosciences, Inc.
- filed_at: 2024-05-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1310527/000149315224017494/0001493152-24-017494-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1310527/000149315224017494/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-017494
- JSON: https://secwatch.observer/filing/0001493152-24-017494.json
- Plain text: https://secwatch.observer/filing/0001493152-24-017494.txt

## Key facts
- Governance Changes
  QSAM Biosciences, Inc.: Effected a 1-for-2,000 reverse stock split via Certificate of Amendment to Amended and Restated Certificate of Incorporation (effective 2024-05-02).
  - Change: charter amendment
  - Effective: 2024-05-02
  source text: QSAM filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation (“ Certificate of Amendment ”) with the Secretary of State of the State of Delaware, to effectuate the Reverse Split with an effective date of May 2, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1310527/000149315224017494/0001493152-24-017494-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.